Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evolving Guidelines for Intracameral Injection.
Liebmann JM, Barton K, Weinreb RN, Eichenbaum DA, Gupta PK, McCabe CM, Wolfe JD, Ahmed I, Sheybani A, Craven ER. Liebmann JM, et al. Among authors: wolfe jd. J Glaucoma. 2020 Mar;29 Suppl 1:S1-S7. doi: 10.1097/IJG.0000000000001451. J Glaucoma. 2020. PMID: 31977546 Review.
Response to Letter to the Editor: Evolving Guidelines for Intracameral Injection.
Eichenbaum DA, Liebmann JM, Barton K, Weinreb RN, Gupta PK, McCabe CM, Wolfe JD, Ahmed I, Sheybani A, Craven ER. Eichenbaum DA, et al. Among authors: wolfe jd. J Glaucoma. 2021 Mar 1;30(3):e123-e124. doi: 10.1097/IJG.0000000000001707. J Glaucoma. 2021. PMID: 33074961 No abstract available.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
Endophthalmitis in Eyes Treated with the Port Delivery System with Ranibizumab: Summary of Cases during Clinical Trial Development.
Eichenbaum DA, Freeman WR, Chang MA, Brooks L, Chaudhry N, Dadgostar H, McCannel CA, Michels M, Mittra RA, Wolfe JD, Beindl VC, Jaycock P, Bobbala A, Gune S, Spicer G, Callaway N. Eichenbaum DA, et al. Among authors: wolfe jd. Ophthalmol Retina. 2024 Aug 16:S2468-6530(24)00368-3. doi: 10.1016/j.oret.2024.08.005. Online ahead of print. Ophthalmol Retina. 2024. PMID: 39154860 Free article.
LONG-TERM USE OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Begaj T, Jeong D, Park JG, Runner MM, Capone A Jr, Dass AB, Drenser KA, Faia LJ, Farley ND, Garretson BR, Hassan TS, Mahmoud TH, Margherio A, Raphaelian PV, Randhawa S, Ruby AJ, Sneed S, Rao P, Wolfe JD, Williams GA. Begaj T, et al. Among authors: wolfe jd. Retina. 2024 Feb 1;44(2):222-229. doi: 10.1097/IAE.0000000000003961. Retina. 2024. PMID: 37903288
Surgical Management of Full-Thickness Macular Holes in Macular Telangiectasia Type 2: A Global Multicenter Study.
Park JG, Adrean SD, Begaj T, Capone A Jr, Charles S, Chen SN, Chou HD, Cohen MN, Corona ST, Faia LJ, Garg SJ, Garretson BR, Gregori NZ, Haller JA, Houghton OM, Hsu J, Jo J, Kaiser RS, Lai CC, Mahgoub MM, Mansoor M, Matoba R, Morizane Y, Nehemy MB, Raphaelian PV, Regillo CD, Ruby AJ, Runner MM, Sneed SR, Sohn EH, Spirn MJ, Vander JF, Wakabayashi T, Wolfe JD, Wykoff CC, Yonekawa Y, Yoon YH, Mahmoud TH. Park JG, et al. Among authors: wolfe jd. Ophthalmology. 2024 Jan;131(1):66-77. doi: 10.1016/j.ophtha.2023.08.025. Epub 2023 Sep 3. Ophthalmology. 2024. PMID: 37661066
115 results